Joel M Kremer Selected Research

Joel M Kremer Research Topics

Disease

125	Rheumatoid Arthritis 12/2023 - 11/2002
10	Infections 03/2021 - 05/2006
8	Fatigue 12/2023 - 01/2017
8	Necrosis 01/2021 - 09/2010
7	Pain (Aches) 12/2023 - 01/2017
5	Psoriatic Arthritis 04/2024 - 08/2003
5	Obesity 11/2022 - 04/2014
5	Arthritis (Polyarthritis) 01/2022 - 04/2014
5	Neoplasms (Cancer) 03/2021 - 05/2006
3	Inflammation (Inflammations) 12/2022 - 06/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 05/2020
3	Herpes Zoster 03/2021 - 12/2015
3	Respiratory Tract Infections (Respiratory Tract Infection) 11/2020 - 04/2012
3	Rheumatic Diseases (Rheumatism) 10/2015 - 11/2008
2	Hypertension (High Blood Pressure) 05/2020 - 04/2014
2	Headache (Headaches) 01/2018 - 04/2012
2	Chronic Disease (Chronic Diseases) 01/2017 - 01/2017
2	Body Weight (Weight, Body) 06/2006 - 11/2003
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024
1	Cytokine Release Syndrome 01/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023
1	Neuromyelitis Optica (Devic's Disease) 01/2023
1	Giant Cell Arteritis (Horton Disease) 01/2023
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023
1	Adult-Onset Still's Disease 01/2023
1	Castleman Disease (Castleman's Disease) 01/2023
1	COVID-19 01/2023
1	Anemia 12/2022
1	Joint Diseases (Joint Disease) 02/2021
1	Neutropenia 10/2020
1	Varicella Zoster Virus Infection 01/2018
1	Fibromyalgia (Fibrositis) 01/2018
1	Nasopharyngitis 01/2018

Drug/Important Bio-Agent (IBA)

37	Methotrexate (Mexate)FDA LinkGeneric 08/2023 - 11/2002
25	Antirheumatic Agents (DMARD)IBA 12/2023 - 05/2006
18	Tumor Necrosis Factor InhibitorsIBA 08/2023 - 08/2003
17	Abatacept (Orencia)FDA Link 06/2021 - 06/2005
15	tocilizumab (atlizumab)FDA Link 03/2021 - 01/2011
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 08/2003
10	Etanercept (Enbrel)FDA Link 01/2021 - 06/2003
8	Janus Kinase InhibitorsIBA 12/2023 - 07/2009
8	Infliximab (Remicade)FDA Link 01/2021 - 08/2003
8	Rituximab (Mabthera)FDA Link 01/2021 - 12/2012
6	tofacitinibIBA 03/2021 - 07/2009
5	Adalimumab (Humira)FDA Link 01/2021 - 07/2009
5	baricitinibIBA 10/2020 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2003
4	Anti-Citrullinated Protein AntibodiesIBA 05/2023 - 06/2019
4	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 06/2021 - 10/2008
4	Leflunomide (Arava)FDA LinkGeneric 01/2018 - 11/2002
3	ametantrone (HAQ)IBA 12/2023 - 01/2017
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2023 - 12/2022
3	AntigensIBA 05/2023 - 11/2003
3	Monoclonal AntibodiesIBA 01/2018 - 01/2015
3	LipidsIBA 01/2018 - 04/2014
3	EnzymesIBA 01/2017 - 02/2006
2	Interleukin-6 (Interleukin 6)IBA 08/2023 - 01/2023
2	GlucocorticoidsIBA 12/2021 - 01/2019
2	AntibodiesIBA 06/2021 - 03/2015
2	cyclic citrullinated peptideIBA 06/2021 - 01/2020
2	golimumab FDA Link 01/2021 - 01/2018
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2021 - 01/2018
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 11/2020
2	Certolizumab Pegol FDA Link 01/2021 - 01/2018
2	acetyl 4-aminosalicylic acidIBA 01/2020 - 06/2019
2	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2018
2	mavrilimumabIBA 01/2018 - 01/2018
2	upadacitinibIBA 01/2018 - 12/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018 - 01/2018
2	Peptides (Polypeptides)IBA 01/2018 - 03/2015
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2014 - 06/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2011 - 06/2003
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2009 - 02/2006
1	ORALIT (ORS)IBA 04/2024
1	secukinumabIBA 04/2024
1	methyl-N-dansylgalactosaminideIBA 12/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 12/2022
1	C-Reactive ProteinIBA 12/2022
1	brassIBA 12/2021
1	vinyltriethoxysilane (VTES)IBA 03/2021
1	omega-Chloroacetophenone (Mace)IBA 03/2021
1	AutoantibodiesIBA 02/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	CreatinineIBA 05/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2020
1	Genetic Markers (Genetic Marker)IBA 12/2019
1	Blood Proteins (Serum Proteins)IBA 10/2019
1	GlycopeptidesIBA 10/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	Prednisone (Sone)FDA LinkGeneric 09/2019
1	ixekizumabIBA 11/2018
1	Janus Kinase 1IBA 01/2018
1	3-benzoyl dopamine (MBDA)IBA 01/2018
1	Anti-Idiotypic AntibodiesIBA 01/2018

Therapy/Procedure

35	Therapeutics 08/2023 - 11/2002
7	Biological Therapy 11/2022 - 02/2014
1	Ambulatory Care (Outpatient Care) 12/2023
1	Treatment Delay 05/2018